cis-tert-Butyl 3-amino-4-fluoropyrrolidine-1-carboxylate

Catalog No. :
ACDGHB250
CAS No. :
1431720-86-3
Molecular Formula :
C9H17FN2O2
Molecular Weight :
204.24

IUPAC Name:tert-butyl (3S,4R)-3-amino-4-fluoropyrrolidine-1-carboxylate

cis-tert-Butyl 3-amino-4-fluoropyrrolidine-1-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
10g95%$91.00Login to see priceInquiryInquiry
25g95%$209.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Namecis-tert-Butyl 3-amino-4-fluoropyrrolidine-1-carboxylate
IUPAC Nametert-butyl (3S,4R)-3-amino-4-fluoropyrrolidine-1-carboxylate
MDL No.MFCD18072719
Molecular FormulaC9H17FN2O2
Molecular Weight204.24
SMILESO=C(N1C[C@H](N)[C@H](F)C1)OC(C)(C)C
InChI KeyDXQXHFOCKKIWJL-RQJHMYQMSA-N
SynonymDXQXHFOCKKIWJL-RQJHMYQMSA-N | AMY35555 | tert-Butyl (3R,4S)-3-amino-4-fluoro-pyrrolidine-1-carboxylate | W-204940 | DTXSID501163513 | CIS-1-BOC-3-AMINO-4-FLUOROPYRROLIDINE | 1431720-86-3 | CS-0058585 | P16314 | DS-8803 | cis-(1-Boc)-3-amino-4-fluoropyrrol
CAS No.1431720-86-3
PubChem CID45489886

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACDGHB250 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACTRMX927 route compound structure diagram
    ACTRMX927555-75-9
  4. Plus
  5. reactant_3 route compound structure diagram
    --
  6. Then
  7. ACDGHB250 route product structure diagram
    ACDGHB2501431720-86-3 In Stock
Inquiry

2. ACDGHB250 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACDGHB250 route product structure diagram
    ACDGHB2501431720-86-3 In Stock
Inquiry

Comments (0)